Icon Bioscience Lands $5,316,245 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Icon Bioscience
  • Mailing Address
    1253 Reamwood Avenue Sunnyvale, CA 94089 USA
  • Company Description
    Icon Bioscience is developing a broad portfolio of advanced, biodegradable, sustained-released intraocular ophthalmic products, based on its Verisome drug delivery technology.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy